GATA2

Clinical trials for GATA2 explained in plain language.

Never miss a new study

Get alerted when new GATA2 trials appear

Sign up with your email to follow new studies for GATA2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

New drug could make stem cell transplants safer for rare immune disorder

⭐️ CURE ⭐️ Ongoing

This study tests a new drug called Briquilimab to see if it can make stem cell transplants safer for people with GATA2 deficiency, a genetic condition that weakens the immune system and raises the risk of infections and blood cancers. About 7 participants aged 6 to 70 will receiv…

Matched conditions: GATA2

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: ⭐️ CURE ⭐️

Last updated May 13, 2026 16:03 UTC

GATA2

Get alerted when new GATA2 trials appear

New drug could make stem cell transplants safer for rare immune disorder